Huasheng Investment joins Asia’s comprehensive cell bank: giving life and youth a chance
On December 21, 2018, accompanied by medical staff, Huasheng Investment Group partners arrived in the Asian comprehensive cell bank for immune cell storage, and the professional medical staff received a warm reception.
Deputy Director of the Integrated Cell Bank of Asia, Deputy Director of the Hong Kong Center of the Center for Translational Medicine at Stanford University, Postdoctoral Researcher in Stem Cell and Drug Research at Harvard Medical School, Ph.D., Postdoctoral Research in Cancer Stem Cell and Drug Research, Cancer Center, University of Hong Kong Medical School, Dr. Wen Yuxian, Canadian Registered Chemist Huasheng Investment Group partners analyze the physical condition and develop a precise storage plan.
Hong Kong Zhongji No. 1 International Medical Group Medical Director, Hong Kong Baptist Hospital Chief Physician, Director of the British Medical Research Centre Dr. Feng Jijia and medical staff for Huasheng Investment Group partners to take peripheral blood for blood testing and storage.
The qualified peripheral blood is collected and monitored by professionals. The person receives the cells, detects them in a sterile and virus-free environment, separates them, and automatically stores them by the liquid nitrogen supply system. The whole storage process is 4 hours.
Japan has incorporated immune cell therapy into routine medical care as early as 2006. The FDA Food and Drug Administration also approved a target vaccine for the treatment of prostate cancer using autoimmune cells in 2012 and included the drug in the medical insurance, and the 2018 Nobel Prize in Physiology or Medicine was awarded to the United States. James P. Allision, an immunologist at the University of Austin, and a professor at Kyoto University in Japan, recognized their discovery of cancer therapies that suppress immune regulation. This means that immune cell therapy technology has become the main way to treat cancer.
Attending doctor of Hong Kong Zhongji 3 International Human Immune System Optimization Center, deputy director of China Center of Translational Medicine Center of Stanford University, and Guo Minghui, MD of Prince of Wales Hospital of Hong Kong, explain the importance of immune cells to the human body and how to improve themselves scientifically. Immunity, and the optimal period of storage of immune cells. Call for more people to focus on health, store immune cells early, prevent disease and fight cancer.
Attending doctor of Hong Kong Zhongji 3 International Human Immune System Optimization Center, deputy director of China Center of Translational Medicine Center of Stanford University, and Guo Minghui, MD of Prince of Wales Hospital of Hong Kong, explain the importance of immune cells to the human body and how to improve themselves scientifically. Immunity, and the optimal period of storage of immune cells. Call for more people to focus on health, store immune cells early, prevent disease and fight cancer.
華盛投資集團合作夥伴和亞洲綜合細胞庫進行合作簽約
華盛投資集團合作夥伴表示，希望聯合亞洲綜合細胞庫將先進的醫療技術和健康理念傳遞給身邊的人，讓更多人少生病，不生病，通過免疫細胞儲存實現健康美好！
華盛投資集團合作夥伴表示，希望聯合亞洲綜合細胞庫將先進的醫療技術和健康理念傳遞給身邊的人，讓更多人少生病，不生病，通過免疫細胞儲存實現健康美好！
